New drug aims to tame dangerous blood fats in heart patients
Disease control
Recruiting now
This study tests an experimental drug called RBD5044 in 120 adults with mixed dyslipidemia, a condition where both cholesterol and triglycerides are high. Participants receive either the drug or a placebo twice over 12 months to see if it safely lowers triglyceride levels. The go…
Phase: PHASE2 • Sponsor: Ribocure Pharmaceuticals AB • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC